Ignite Creation Date:
2025-12-25 @ 4:48 AM
Ignite Modification Date:
2026-03-09 @ 9:19 PM
Study NCT ID:
NCT04681118
Status:
NO_LONGER_AVAILABLE
Last Update Posted:
2024-04-23
First Post:
2020-12-18
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Expanded Access Protocol: Repeated Administration of Nurown® (Autologous MSC-NTF Cells) for the Treatment of ALS
Sponsor:
Brainstorm-Cell Therapeutics
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Amyotrophic Lateral Sclerosis | View |
Keywords: